Sequential Field Therapy in Actinic Keratosis: A Mechanism-Based Rationale for Complementary Treatment Strategies
Journal of Clinical Medicine · 11.06.2026 · 15 (12) · 4553
DOI: 10.3390/jcm15124553 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.06.2026. Verfasst von Giulio Gualdi und 9 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital, Ospedale Maggiore di Parma, 43126 Parma, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Actinic keratoses are common keratinocytic precursor lesions arising within chronically ultraviolet-damaged skin and are associated with an increased risk of progression to cutaneous squamous cell carcinoma. The concept of field cancerization has shifted therapeutic strategies from the treatment of isolated visible lesions toward broader field-directed approaches targeting both clinical and subclinical disease.
Methods
This narrative review summarizes the rationale, mechanisms of action, efficacy profile, tolerability, and practical limitations of currently available field-directed therapies for actinic keratosis, including 5-fluorouracil, imiquimod, diclofenac, photodynamic therapy, and tirbanibulin. Based on their distinct biological targets, we propose a mechanism-based framework for sequential treatment strategies.
Results
Available therapies act through partially non-overlapping mechanisms, including cytotoxic activity, immune activation, cyclooxygenase-2 inhibition, photodynamic oxidative damage, and tubulin/Src pathway inhibition. These complementary effects provide a biological rationale for sequential regimens aimed at addressing the heterogeneity of field cancerization. However, direct clinical evidence supporting specific treatment sequences remains limited, and proposed regimens should be interpreted as hypothesis-generating rather than as validated therapeutic protocols.
Conclusions
Mechanism-based sequential field therapy may represent a rational strategy to optimize long-term control of actinic keratosis and field cancerization. Prospective comparative studies are needed to define optimal sequences, treatment intervals, patient selection criteria, and clinically meaningful endpoints, including sustained field clearance, recurrence reduction, tolerability, adherence, and prevention of progression to invasive cutaneous squamous cell carcinoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Hospital, Ospedale Maggiore di Parma, 43126 Parma, Italy.
- Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.
- Skin Cancer Center, Istituto Dermopatico dell'Immacolata-IRCCS, 00167 Rome, Italy.
- Department of Life Science, Health, and Health Professions, Link University of Rome, 00168 Rome, Italy.
- Dermatology Clinic, Sassuolo Hospital, 41049 Sassuolo, Italy.
- Dermatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.
ORCID-Profile: Giulio Gualdi, Patrick Silvetti, Leonardo Balestra, Davide Bertolla, Francesco Ricci, Mario Puviani
Zitieren
APA
Gualdi, G., Soligon, G., Silvetti, P., Balestra, L., Bertolla, D., Fania, L., Ricci, F., Puviani, M., Sbano, P., & Paradisi, A. (2026). Sequential Field Therapy in Actinic Keratosis: A Mechanism-Based Rationale for Complementary Treatment Strategies. Journal of Clinical Medicine, 15(12), 4553. https://doi.org/10.3390/jcm15124553
Vancouver
Gualdi G, Soligon G, Silvetti P, Balestra L, Bertolla D, Fania L, et al. Sequential Field Therapy in Actinic Keratosis: A Mechanism-Based Rationale for Complementary Treatment Strategies. Journal of Clinical Medicine. 2026;15(12):4553. doi:10.3390/jcm15124553
BibTeX
@article{Gualdi2026,
author = {Gualdi, Giulio and Soligon, Gabriele and Silvetti, Patrick and Balestra, Leonardo and Bertolla, Davide and Fania, Luca and Ricci, Francesco and Puviani, Mario and Sbano, Paolo and Paradisi, Andrea},
title = {Sequential Field Therapy in Actinic Keratosis: A Mechanism-Based Rationale for Complementary Treatment Strategies},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4553},
doi = {10.3390/jcm15124553}
}
EUVIMED